G. Gaughran

发表

The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer

B. Shadbolt, R. Stuart-Harris, N. Aggarwal, 2020 .

Vedolizumab in combined immune checkpoint therapy-induced infliximab-refractory colitis in a patient with metastatic melanoma: A case report

P. Pavli, A. Morey, D. Yip, 2019, World journal of clinical oncology.

Combined immune therapy grade IV dermatitis in metastatic melanoma

A. Morey, D. Yip, G. Gaughran, 2019, Asia-Pacific journal of clinical oncology.

Improving regional access: Phase 1 teletrials in the era of COVID‐19

J. Zalcberg, M. Shackleton, G. Gaughran, 2021, Asia-Pacific journal of clinical oncology.

A comparative study of the osteology and myology of the cranial and cervical regions of the shrew, Blarina brevicauda, and the mole, Scalopus aquaticus.

G. Gaughran, 1954 .

Carboplatin and hypomagnesemia: Is it really a problem?

L. Smyth, Alison Davis, G. Gaughran, 2020, Asia-Pacific journal of clinical oncology.

Young adults diagnosed with high grade gliomas: Patterns of care, outcomes, and impact on employment

H. Gan, A. Nowak, G. Gaughran, 2019, Journal of clinical neuroscience.

Radionuclide liver spots: indicator of liver disease or a blood flow phenomenon.

G. Gaughran, R. Kusumi, M. Tetalman, 1978, AJR. American journal of roentgenology.

Teaching neuroimages: ‘Blind drunk’: neuroimaging findings in methanol poisoning

M. Bynevelt, N. Lawn, G. Gaughran, 2016, Acta Neurologica Belgica.